View Filing Data

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2017	Aug. 07, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q2
Entity Registrant Name	XCel Brands, Inc.
Entity Central Index Key	0001083220
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	XELB
Entity Common Stock, Shares Outstanding		18,471,001

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current Assets:
Cash and cash equivalents	$ 7,621	$ 14,127
Accounts receivable, net	8,748	6,969
Prepaid expenses and other current assets	876	807
Total current assets	17,245	21,903
Property and equipment, net	2,520	2,600
Trademarks and other intangibles, net	110,673	111,220
Goodwill	12,371	12,371
Restricted cash	1,509	1,509
Other assets	1,505	1,517
Total non-current assets	128,578	129,217
Total Assets	145,823	151,120
Current Liabilities:
Accounts payable, accrued expenses and other current liabilities	1,054	1,523
Accrued payroll	1,261	2,185
Deferred revenue	73	234
Current portion of long-term debt	3,943	6,427
Current portion of long-term debt, contingent obligations	100	0
Total current liabilities	6,431	10,369
Long-Term Liabilities:
Long-term debt, less current portion	22,019	25,495
Deferred tax liabilities, net	7,914	6,901
Other long-term liabilities	2,472	2,181
Total long-term liabilities	32,405	34,577
Total Liabilities	38,836	44,946
Commitments and Contingencies
Stockholders' Equity:
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding	0	0
Common stock, $.001 par value, 35,000,000 shares authorized at June 30, 2017 and December 31, 2016, and 18,471,001 and 18,644,982 issued and outstanding at June 30, 2017 and December 31, 2016, respectively	18	19
Paid-in capital	98,354	97,354
Retained earnings	8,615	8,801
Total Stockholders' Equity	106,987	106,174
Total Liabilities and Stockholders' Equity	$ 145,823	$ 151,120

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2017	Dec. 31, 2016
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	35,000,000	35,000,000
Common stock, shares issued	18,471,001	18,644,982
Common stock, shares outstanding	18,471,001	18,644,982

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenues
Net revenues	$ 8,370	$ 9,112	$ 16,800	$ 17,473
Operating costs and expenses
Salaries, benefits and employment taxes	4,360	4,217	8,727	8,427
Other design and marketing costs	645	831	1,516	1,660
Other selling, general and administrative expenses	1,134	2,020	2,414	3,365
Stock-based compensation	723	1,453	1,806	2,665
Depreciation and amortization	390	359	784	785
Total operating costs and expenses	7,252	8,880	15,247	16,902
Operating income
Operating income	1,118	232	1,553	571
Interest and finance expense
Interest expense - term debt	304	352	632	663
Other interest and finance charges	44	178	94	302
Total interest and finance expense	348	530	726	965
Income (loss) before income taxes	770	(298)	827	(394)
Income tax provision (benefit)	557	(208)	1,013	(259)
Net income (loss)	$ 213	$ (90)	$ (186)	$ (135)
Basic net income (loss) per share	$ 0.01	$ (0.00)	$ (0.01)	$ (0.01)
Diluted net income (loss) per share	$ 0.01	$ (0.00)	$ (0.01)	$ (0.01)
Basic weighted average common shares outstanding	18,449,210	18,671,648	18,561,453	18,565,198
Diluted weighted average common shares outstanding	18,813,044	18,671,648	18,561,453	18,565,198

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities
Net loss	$ (186)	$ (135)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization expense	784	785
Amortization of deferred finance costs	99	94
Stock-based compensation	1,806	2,665
Amortization of note discount	19	158
Deferred income tax	1,013	(259)
Non-cash property exit charge	0	648
Changes in operating assets and liabilities:
Accounts receivable	(1,779)	(2,484)
Prepaid expenses and other assets	(67)	92
Accounts payable, accrued expenses and other current liabilities	(1,394)	449
Deferred revenue	(161)	(558)
Other liabilities	290	875
Net cash provided by operating activities	424	2,330
Cash flows from investing activities
Cost to acquire intangible assets	(18)	0
Purchase of property and equipment	(140)	(1,718)
Net cash used in investing activities	(158)	(1,718)
Cash flows from financing activities
Proceeds from exercise of stock options	0	20
Shares repurchased including vested restricted stock in exchange for withholding taxes	(806)	(302)
Payment of deferred finance costs	(7)	(69)
Payment of long-term debt	(5,959)	(3,000)
Payment of QVC earn-out obligation	0	(250)
Net cash used in financing activities	(6,772)	(3,601)
Net decrease in cash and cash equivalents	(6,506)	(2,989)
Cash, cash equivalents, and restricted cash at beginning of period	15,636	17,969
Cash, cash equivalents, and restricted cash at end of period	9,130	14,980
Reconciliation to amounts on condensed consolidated balance sheets:
Cash and cash equivalents	7,621	13,471
Restricted cash	1,509	1,509
Total cash, cash equivalents, and restricted cash	15,636	17,969
Supplemental disclosure of cash flow information:
Cash paid during the period for income taxes	144	118
Cash paid during the period for interest	$ 677	$ 560

Nature of Operations, Background, and Basis of Presentation

6 Months Ended

Jun. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2016 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. (“Xcel”) and its subsidiaries (the “Company”). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, as filed with the SEC on March 24, 2017.

The Company is a media and brand management company engaged in the design, production, licensing, marketing, and direct to consumer sales of branded apparel, footwear, accessories, jewelry, home goods, and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Currently, the Company’s brand portfolio consists of the Isaac Mizrahi brand (the "Isaac Mizrahi Brand"), the Judith Ripka brand (the “Ripka Brand”), the H by Halston and H Halston brands (collectively, the “H Halston Brands”), the C Wonder brand (the “C Wonder Brand”), and the Highline Collective brand.

The Company licenses its brands to third parties, provides certain design, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements with manufacturers and retailers. These activities include licensing its own brands for promotion and distribution through a ubiquitous retail sales strategy, which encompasses distribution through interactive television, the internet, and traditional brick-and-mortar retail channels.

Certain reclassifications have been made to the prior period unaudited condensed consolidated financial statements to conform to the current period presentation, including:

⋅

Presentation of e-commerce gross margin within total net revenues on the condensed consolidated statements of operations. Of the $36,000 of costs previously presented as cost of goods sold for the three months ended June 30, 2016, $4,000 has been reclassified to net revenues, and $32,000 has been reclassified to other selling, general and administrative expenses. Of the $106,000 of costs previously presented as cost of goods sold for the six months ended June 30, 2016, $35,000 has been reclassified to net revenues, and $71,000 has been reclassified to other selling, general and administrative expenses.

⋅

Presentation of restricted cash on the condensed consolidated statements of cash flows, as a result of the early adoption of Accounting Standards Update No. 2016-18 in the fourth quarter of 2016.

For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

Recent Accounting Pronouncements

In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2017-09, Stock Compensation (Topic 718): Scope of Modification Accounting (“ASU 2017-09”). ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. An entity should account for the effects of a modification unless all the following conditions are met: (i) the fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified; (ii) the vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified; and (iii) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. This new accounting guidance is effective for public companies for fiscal years beginning after December 15, 2017 (i.e., calendar years beginning on January 1, 2018), including interim periods within those fiscal years. Early adoption is permitted in any interim or annual period. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. The Company is currently evaluating the impact that the adoption of ASU 2017-09 will have on the Company’s consolidated financial statements.

In May 2014, FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), requiring revenue to be recognized in an amount that reflects the consideration expected to be received in exchange for goods and services. This new revenue standard may be applied retrospectively to each prior period presented, or retrospectively with the cumulative effect recognized as of the date of adoption. In August 2015, FASB issued ASU No. 2015-14, Revenue from Contracts with Customers – Deferral of the Effective Date (“ASU 2015-14”), which defers implementation of ASU 2014-09 by one year. Under such deferral, the adoption of ASU 2014-09 becomes effective for us on January 1, 2018, including interim periods within that reporting period. Early adoption is permitted, but not before our original effective date of January 1, 2017. Our evaluation of the impact of the adoption of ASU 2014-09 on our consolidated financial statements is ongoing and our implementation efforts have included the identification of revenue within the scope of the guidance and the evaluation of applicable revenue contracts. Currently, based on our preliminary analyses, we do not expect the adoption of ASU 2014-09 to result in material differences from the Company’s current revenue recognition policies; however, our analyses are not final. The Company recognizes revenue continuously over time as it satisfies its continuous obligation of granting access to its licensed intellectual properties. Revenue, depending on the contract, is recognized ratably over each contract year as the performance occurs based on the greater of the guaranteed minimum payments, sales-based payments, or performance based payments, with each contract year treated as separate from the other years.

Trademarks, Goodwill and Other Intangibles

6 Months Ended

Jun. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

Trademarks, Goodwill and Other Intangibles

Trademarks and other intangibles, net consist of the following:

		June 30, 2017
	Weighted-
	Average
	Amortization	Gross Carrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	96,694	$	-	$	96,694
Trademarks (definite-lived)	15 years		15,463		1,973		13,490
Licensing agreements	4 years		2,000		2,000		-
Non-compete agreement	7 years		562		201		361
Copyrights and other intellectual property	10 years		190		62		128
Total		$	114,909	$	4,236	$	110,673

		December 31, 2016
	Weighted-
	Average
	Amortization	Gross Carrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	96,676	$	-	$	96,676
Trademarks (definite-lived)	15 years		15,463		1,459		14,004
Licensing agreements	4 years		2,000		2,000		-
Non-compete agreement	7 years		562		160		402
Copyrights and other intellectual property	10 years		190		52		138
Total		$	114,891	$	3,671	$	111,220

Amortization expense for intangible assets was approximately $282,000 for each of the quarters ended June 30, 2017 (the “Current Quarter”) and June 30, 2016 (the “Prior Year Quarter”). Amortization expense for intangible assets for the six months ended June 30, 2017 (“Current Six Months”) and the six months ended June 30, 2017 (the “Prior Year Six Months”) was approximately $565,000 and $564,000, respectively.

The trademarks related to the Isaac Mizrahi Brand, the Ripka Brand, and the H Halston Brands have been determined to have indefinite useful lives and, accordingly, no amortization has been recorded for these assets.

The Company has $12.371 million of goodwill related to the 2011 acquisition of the Isaac Mizrahi business. There was no change in goodwill during the Current Six Months.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Significant Contracts

6 Months Ended

Jun. 30, 2017

Significant Contracts [Abstract]

Significant Contracts [Text Block]

Significant Contracts

QVC Agreements

Under the Company’s agreements with QVC, QVC is required to pay the Company fees based primarily on a percentage of its net sales of Isaac Mizrahi, Ripka, H Halston, and C Wonder branded merchandise. QVC royalty revenue represents a significant portion of the Company’s total revenues. Net revenues from QVC totaled $6.78 million and $7.72 million for the Current Quarter and Prior Year Quarter, respectively, representing approximately 81% and 85% of the Company’s net revenues, respectively. Net revenues from QVC totaled $14.01 million and $14.95 million for the Current Six Months and the Prior Year Six Months, respectively, representing approximately 83% and 86% of the Company’s net revenues, respectively. As of June 30, 2017 and December 31, 2016, the Company had receivables from QVC of $6.83 million and $5.89 million, respectively, representing approximately 78% and 85% of the Company’s total receivables, respectively.

On April 28, 2017, the Company and QVC entered into an amendment to terminate the C Wonder QVC Agreement effective May 1, 2017 and commence a sell-off period. During the sell-off period, QVC remains obligated to pay royalties to the Company through January 31, 2018, and QVC retains exclusive rights with respect to C Wonder branded products for interactive television, excluding certain permitted international entities, through May 1, 2018.

Debt

6 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

Debt

The Company’s net carrying amount of debt was comprised of the following:

	June 30,		December 31,
($ in thousands)	2017		2016
Xcel Term Loan	$	20,000	$	25,250
Unamortized deferred finance costs related to term loan		(429)		(509)
IM Seller Note		2,918		3,627
Ripka Seller Notes		523		504
Contingent obligation - JR Seller		200		200
Contingent obligation - CW Seller		2,850		2,850
Total		26,062		31,922
Current portion (i)		4,043		6,427
Long-term debt	$	22,019	$	25,495

(i)

The current portion of long-term debt as of June 30, 2017 consists of (a) $2.5 million related to the Xcel Term Loan, (b) $1.443 million related to the IM Seller Note, and (c) $100 thousand related to the Ripka Earn-Out.

Xcel Term Loan

On February 26, 2016, Xcel and its wholly owned subsidiaries, IM Brands, LLC, JR Licensing, LLC, H Licensing, LLC, C Wonder Licensing, LLC, Xcel Design Group, LLC, IMNY Retail Management, LLC, and IMNY E-Store, USA, LLC (each a “Guarantor” and collectively, the “Guarantors”), as Guarantors, entered into an Amended and Restated Loan and Security Agreement (the “Loan Agreement”) with Bank Hapoalim B.M. (“BHI”), as agent (the “Agent”), and the financial institutions party thereto as lenders (the “Lenders”). The Loan Agreement amended and restated the IM Term Loan, the JR Term Loan, and the H Term Loan. Pursuant to the Loan Agreement, Xcel assumed the obligations of each of IM Brands, LLC, JR Licensing, LLC, and H Licensing, LLC under the respective term loans with BHI in the aggregate principal amount of $27,875,000 (the loan under the Loan Agreement is referred to as the “Xcel Term Loan”). Management assessed and determined that this amendment represented a debt modification and, accordingly, no gain or loss was recorded.

On February 24, 2017, Xcel and BHI amended the terms of the Loan Agreement (the “Amended Loan Agreement”). Under this amendment, principal payments for the year ending December 31, 2017 were increased by a total of $1,000,000, principal payments for the year ending December 31, 2021 were decreased by $1,000,000, and the minimum EBITDA (as defined in the Amended Loan Agreement) requirement for the year ended December 31, 2016 was eliminated. There were no changes to the total principal balance, interest rate, maturity date, or other terms of the Loan Agreement. Management assessed and determined that this amendment represented a debt modification and, accordingly, no gain or loss was recorded.

On June 15, 2017, Xcel and BHI entered into a second amendment to the Amended Loan Agreement. Under this amendment, principal payments for the year ending December 31, 2017 were increased by a total of $750,000, principal payments for the year ending December 31, 2021 were decreased by $750,000, the minimum EBITDA (as defined in the Second Amendment to the Amended Loan Agreement) requirement for the year ending December 31, 2017 was changed from $9,000,000 to $7,000,000, and the minimum EBITDA requirements for the years ending December 31, 2018 and 2019 were changed from $9,000,000 to $8,000,000. There were no changes to the total principal balance, interest rate, maturity date, or other terms of the Loan Agreement. Management assessed and determined that this amendment represented a debt modification and, accordingly, no gain or loss was recorded.

The Xcel Term Loan matures on January 1, 2021. Principal on the Xcel Term Loan is payable in quarterly installments on each of January 1, April 1, July 1 and October 1. As of June 30, 2017, the aggregate remaining scheduled annual principal payments under the Second Amendment to the Amended Loan Agreement were as follows:

($ in thousands)	Amount of
	Principal
Year Ending December 31,	Payment
2017 (July 1 through December 31)	$	500
2018		4,000
2019		4,000
2020		4,000
2021		7,500
Total	$	20,000

Commencing with the fiscal year ending December 31, 2017, the Company is required to repay a portion of the Xcel Term Loan in an amount equal to 10% of the excess cash flow for the fiscal year; provided that no early termination fee shall be payable with respect to any such payment (the “Excess Cash Flow Principal Payment”). Excess cash flow means, for any period, cash flow from operations (before certain permitted distributions) less (i) capital expenditures not made through the incurrence of indebtedness, (ii) all cash interest and principal and taxes paid or payable during such period, and (iii) all dividends declared and paid during such period to equity holders of any credit party treated as a disregarded entity for tax purposes. As of June 30, 2017, the estimated Excess Cash Flow Principal Payment provision of the Xcel Term Loan does not result in any additional repayment during the year ending December 31, 2017.

Under the Amendment to the Loan Agreement, the Company has the right to prepay the Xcel Term Loan, provided that any prepayment of less than all of the outstanding balance shall be applied to the remaining amounts due in inverse order of maturity. If the Xcel Term Loan is prepaid on or prior to the third anniversary of the closing date (including as a result of an event of default), the Company shall pay an early termination fee equal to the principal amount outstanding under the Xcel Term Loan on the date of prepayment, multiplied by: (i) two percent (2.00%) if the Xcel Term Loan is prepaid on or after the closing date and on or before the second anniversary of the closing date; or (ii) one percent (1.00%) if the Xcel Term Loan is prepaid after the second anniversary of the closing date and on or before the third anniversary of the closing date.

Xcel’s obligations under the Amended Loan Agreement are guaranteed by the Guarantors and secured by all of the assets of Xcel and the Guarantors (as well as any subsidiary formed or acquired that becomes a credit party to the Amended Loan Agreement) and, subject to certain limitations contained in the Amended Loan Agreement, equity interests of the Guarantors (as well as any subsidiary formed or acquired that becomes a credit party to the Amended Loan Agreement).

The Amended Loan Agreement contains customary covenants, including reporting requirements, trademark preservation, and the following financial covenants of the Company (on a consolidated basis with the Guarantors and any subsidiaries subsequently formed or acquired that become a credit party under the Amended Loan Agreement):

⋅

net worth (as defined in the Amended Loan Agreement) of at least $90,000,000 at the end of each fiscal quarter ending on June 30 and December 31 of each fiscal year;

⋅

liquid assets of at least $5,000,000, until such time as the ratio of indebtedness to EBITDA (as defined in the Amended Loan Agreement) is less than 1.00 to 1.00 and, in which event, liquid assets must be at least $3,000,000;

⋅

a fixed charge ratio of at least 1.20 to 1.00 for each fiscal quarter ended June 30 and December 31 for the twelve fiscal month period ending on such date;

⋅

capital expenditures shall not exceed (i) $2,650,000 for the year ended December 31, 2016 and (ii) $700,000 for any fiscal year thereafter; and

⋅

EBITDA (as defined in the Amended Loan Agreement) of not less than $7,000,000 for the fiscal year ending December 31, 2017, not less than $8,000,000 for the fiscal years ending December 31, 2018 and 2019, and not less of $9,000,000 for the following fiscal years.

The Company was in compliance with all applicable covenants as of June 30, 2017.

Interest on the Xcel Term Loan accrues at a fixed rate of 5.1% per annum and is payable on each day on which the scheduled principal payments are required to be made. For the Current Quarter and Prior Year Quarter, the Company incurred interest expense on its senior term loan debt with BHI of approximately $287,000 and $348,000, respectively. For the Current Six Months and Prior Year Six Months, the Company incurred interest expense on its senior term loan debt with BHI of approximately $596,000 and $663,000, respectively.

IM Seller Note

On September 29, 2011, as part of the consideration for the purchase of the Isaac Mizrahi Business, the Company issued to IM Ready-Made, LLC (“IM Ready”) a promissory note in the principal amount of $7,377,000 (as amended, the “IM Seller Note”). The stated interest rate of the IM Seller Note was 0.25% per annum. Management determined that this rate was below the Company’s expected borrowing rate, which was then estimated at 9.25% per annum. Therefore, the Company discounted the IM Seller Note by $1,740,000 using a 9.0% imputed annual interest rate, resulting in an initial value of $5,637,000. In addition, on September 29, 2011, the Company prepaid $123,000 of interest on the IM Seller Note. The imputed interest amount was amortized over the term of the IM Seller Note and recorded as other interest and finance expense on the Company’s condensed consolidated statements of operations.

On December 24, 2013, the IM Seller Note was amended to (1) revise the maturity date to September 30, 2016, (2) revise the date to which the maturity date may be extended to September 30, 2018, (3) provide the Company with a prepayment right with its common stock, subject to remitting in cash certain required cash payments and a minimum common stock price of $4.50 per share, and (4) require interim scheduled payments.

On September 19, 2016, the IM Seller Note was further amended and restated to (1) revise the maturity date to March 31, 2019, (2) require six semi-annual principal and interest installment payments of $750,000, commencing on September 30, 2016 and ending on March 31, 2019, (3) revise the stated interest rate to 2.236% per annum, (4) allow for optional prepayments at any time at the Company’s discretion without premium or penalty, and (5) require that all payments of principal and interest be made in cash. Management assessed and determined that this amendment represented a debt modification and, accordingly, no gain or loss was recorded.

As of June 30, 2017, the aggregate remaining annual principal payments under the IM Seller Note were as follows:

($ in thousands)	Amount of
	Principal
Year Ending December 31,	Payment
2017 (July 1 through December 31)	$	717
2018		1,459
2019		742
Total	$	2,918

For the Current Quarter, the Company incurred interest expense of $16,000 under the IM Seller Note. For the Prior Year Quarter, the Company incurred interest expense of $69,000, which consisted solely of amortization of the discount on the IM Seller Note. For the Current Six Months, the Company incurred interest expense of $36,000 under the IM Seller Note. For the Prior Year Six Months, the Company incurred interest expense of $140,000 under the IM Seller Note, which consisted solely of amortization of the discount on the IM Seller Note.

Ripka Seller Notes

As of June 30, 2017, the remaining discounted balance, non-interest bearing note relating to the acquisition of the Ripka Brand (the “Ripka Seller Notes”) was $523,000. An aggregate $600,000 principal amount of the Ripka Seller Notes is due at maturity (March 31, 2019).

For both the Current Quarter and Prior Year Quarter, the Company incurred interest expense of approximately $9,000 under the Ripka Seller Notes, which consisted solely of amortization of the discount on the Ripka Seller Notes. For the Current Six Months and the Prior Year Six Months, the Company incurred interest expense of approximately $19,000 and $17,000, respectively, under the Ripka Seller Notes, which consists solely of amortization of the discount on the Ripka Seller Notes.

Contingent Obligation – JR Seller (Ripka Earn-Out)

In connection with the purchase of the Ripka Brand, the Company agreed to pay the sellers of the Ripka Brand additional consideration of up to $5 million in aggregate (the “Ripka Earn-Out”), payable in cash or shares of the Company’s common stock based on the fair market value of the Company’s common stock at the time of payment, and with a floor of $7.00 per share, based on the Ripka Brand achieving in excess of $1 million of net royalty income during each of the 12-month periods ending on October 1, 2016, 2017 and 2018, less the sum of all earn-out payments for any prior earn-out period. Net royalty income does not include any revenues generated by interactive television sales or any revenue accelerated as a result of a termination of any license agreement. The Ripka Earn-Out of $3.78 million was recorded based on the difference between the fair value of the acquired assets of the Ripka Brand at the acquisition date and the total consideration paid.

On December 21, 2016, the Company entered into an agreement with the sellers of the Ripka Brand which amended the terms of the Ripka Earn-Out, such that the maximum amount of earn-out consideration was reduced to $375,000, of which $175,000 was payable in cash upon execution of the amendment, and $100,000 is payable in cash on each of May 15, 2018 and 2019. The payment of the remaining future payments of $200,000 under the earn-out is contingent upon the Ripka Brand achieving at least $6,000,000 of net royalty income from QVC during each of the 12-month periods ending on March 31, 2018 and 2019. The remaining expected value (which approximates fair value) of the Ripka Earn-Out of $0.20 million is recorded as long-term debt in the accompanying condensed consolidated balance sheets, of which $0.10 million is presented in the current portion of long-term debt.

Contingent Obligations – CW Seller (C Wonder Earn-Out)

In connection with the purchase of the C Wonder Brand, the Company agreed to pay the seller additional consideration (the “C Wonder Earn-Out”), which would be payable, if at all, in cash or shares of common stock of the Company, at the Company’s sole discretion, after June 30, 2019, with a value based on the royalties related directly to the assets the Company acquired pursuant to the purchase agreement. The value of the earn-out shall be calculated as the positive amount, if any, of (i) two times (A) the maximum net royalties as calculated for any single twelve month period commencing on July 1 and ending on June 30 between the closing date and June 30, 2019 (each, a “Royalty Target Year”) less (B) $4,000,000, plus (ii) two times the maximum royalty determined based on a percentage of retail and wholesale sales of C Wonder branded products by the Company as calculated for any single Royalty Target Year. The C Wonder Earn-Out of $2.85 million is recorded in the accompanying condensed consolidated balance sheets based on the probability of the C Wonder Brand achieving certain net royalty income targets within the earn-out periods and then calculating the present value of the weighted average payment amount. In accordance with Accounting Standards Codification Topic 480, the C Wonder Earn-Out obligation is classified as a liability in the accompanying condensed consolidated balance sheets because of the variable number of shares payable under the agreement.

As of June 30, 2017 and December 31, 2016, total contingent obligations were $3.05 million.

Stockholders' Equity

6 Months Ended

Jun. 30, 2017

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Stockholders’ Equity

2011 Equity Incentive Plan

The Company’s 2011 Equity Incentive Plan, as amended and restated (the “Plan”), is designed and utilized to enable the Company to provide its employees, officers, directors, consultants, and others whose past, present, and/or potential contributions to the Company have been, are, or will be important to the success of the Company, an opportunity to acquire a proprietary interest in the Company. A total of 13,000,000 shares of common stock are eligible for issuance under the Plan. The Plan provides for the grant of any or all of the following types of awards: stock options, restricted stock, deferred stock, stock appreciation rights, and other stock-based awards. The Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

The fair value of options and warrants is estimated on the date of grant using the Black-Scholes option pricing model. The valuation determined by the Black-Scholes option pricing model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The risk-free rate is based on the U.S. Treasury rate for the expected life at the time of grant, volatility is based on the average long-term implied volatilities of peer companies, and expected life is based on the estimated average of the life of options and warrants using the simplified method. The Company utilizes the simplified method to determine the expected life of the options and warrants due to insufficient exercise activity during recent years as a basis from which to estimate future exercise patterns. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts.

Restricted stock awards are valued using the fair value of the Company’s stock at the date of grant.

For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s).

Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur.

Stock Options

Options granted under the Plan expire at various times – either five, seven, or ten years from the date of grant, depending on the particular grant.

On January 1, 2017, the Company granted options to purchase an aggregate of 150,000 shares of common stock to a certain key employee. The exercise price of the options is $5.50 per share, and one-third of the options will vest on each of January 1, 2018, January 1, 2019, and January 1, 2020.

On January 24, 2017, the Company granted options to purchase an aggregate of 500,000 shares of common stock to a certain executive. The exercise price of the options is $5.00 per share, and one-fifth of the options will vest on each of January 1, 2018, January 1, 2019, January 1, 2020, January 1, 2021, and January 1, 2022.

On March 31, 2017, the Company granted options to purchase an aggregate of 150,000 shares of common stock to non-management directors. The exercise price of the options is $2.70 per share, and 50% of the options will vest on each of March 31, 2018 and March 31, 2019.

On May 31, 2017, the Company granted options to purchase an aggregate of 15,000 shares of common stock to a certain key employee. The exercise price of the options is $2.60 per share, and one-third of the options will vest on each of May 31, 2018, May 31, 2019, and May 31, 2020.

The fair values of the options granted during the Current Six Months were estimated at the date of grant using the Black-Scholes option pricing model with the following assumptions:

Expected Volatility	33.69 – 35.20	%
Expected Dividend Yield	0	%
Expected Life (Term)	3.25 – 5.42 years
Risk-Free Interest Rate	1.52 – 2.02	%

A summary of the Company’s stock options activity for the Current Six Months is as follows:

					Weighted
					Average
			Weighted		Remaining
			Average		Contractual		Aggregate
	Number of		Exercise		Life		Intrinsic
	Options		Price		(in Years)		Value
Outstanding at January 1, 2017		2,436,000	$	5.98		4.38	$	-
Granted		815,000		4.62
Canceled		-		-
Exercised		-		-
Expired/Forfeited		(93,000)		5.02
Outstanding at June 30, 2017, and expected to vest		3,158,000	$	5.66		4.54	$	-
Exercisable at June 30, 2017		811,670	$	6.01		3.61	$	-

Compensation expense related to stock options for the Current Quarter and the Prior Year Quarter was approximately $272,000 and $329,000, respectively. Compensation expense related to stock options for the Current Six Months and the Prior Year Six Months was approximately $574,000 and $349,000, respectively. Total unrecognized compensation expense related to unvested stock options at June 30, 2017 amounts to approximately $2,515,000 and is expected to be recognized over a weighted average period of 2.48 years.

The following table summarizes the Company’s stock option activity for non-vested options for the Current Six Months:

			Weighted
			Average
	Number of		Grant Date
	Options		Fair Value
Balance at January 1, 2017		2,294,667	$	1.39
Granted		815,000		1.07
Vested		(670,337)		1.49
Forfeited or Canceled		(93,000)		1.01
Balance at June 30, 2017		2,346,330	$	1.32

Warrants

Warrants granted under the Plan expire at various times – either five, seven, or ten years from the date of grant, depending on the particular grant.

A summary of the Company’s warrants activity for the Current Six Months is as follows:

					Weighted
					Average
			Weighted		Remaining
			Average		Contractual		Aggregate
	Number of		Exercise		Life		Intrinsic
	Warrants		Price		(in Years)		Value
Outstanding and exercisable at January 1, 2017		1,966,743	$	6.76		2.81	$	-
Granted		-		-
Canceled		-		-
Exercised		-		-
Expired/Forfeited		(75,000)		(5.50)
Outstanding and exercisable at June 30, 2017		1,891,743	$	6.81		2.42	$	-

No compensation expense was recognized in the Current Six Months or Prior Year Six Months related to warrants.

Restricted Stock

On January 31, 2017, the Company issued 50,000 shares of restricted stock to a consulting firm whose controlling shareholder is a director of the Company. Of the 50,000 shares of restricted stock granted, 25,000 shares vested immediately and 25,000 shares shall vest on January 31, 2018. On June 18, 2017, the Company issued an additional 28,334 shares of restricted stock to the same consulting firm, of which 14,167 shares vested immediately on the same day and 14,167 shares shall vest on January 31, 2018. See Note 8, Related Party Transactions, for additional information.

On March 31, 2017, the Company issued to non-management directors an aggregate of 48,000 shares of restricted stock. The shares of restricted stock will vest evenly over two years, whereby 50% shall vest on March 31, 2018 and 50% shall vest on March 31, 2019.

Notwithstanding the foregoing, each executive and director grantee may extend the first anniversary of all or a portion of the restricted stock by six months and, thereafter one or more times may further extend such date with respect to all or a portion of the restricted stock until the next following date six months or twelve months hence, by providing written notice of such election to extend such date with respect to all or a portion of the restricted stock prior to such date.

A summary of the Company’s restricted stock activity for the Current Six Months is as follows:

			Weighted
	Number of		Average
	Restricted		Grant Date
	Shares		Fair Value
Outstanding at January 1, 2017		3,171,685	$	5.12
Granted		126,334		3.18
Canceled		-		-
Vested		(768,431)		4.20
Expired/Forfeited		(1,000)		9.00
Outstanding at June 30, 2017		2,528,588	$	5.29

Compensation expense related to restricted stock grants for the Current Quarter and Prior Year Quarter was approximately $451,000 and $1,124,000, respectively. Compensation expense related to restricted stock grants for the Current Six Months and Prior Year Six Months was approximately $1,232,000 and $2,316,000, respectively. Total unrecognized compensation expense related to unvested restricted stock grants at June 30, 2017 amounts to approximately $1,169,000 and is expected to be recognized over a weighted average period of 1.65 years.

Shares Available Under the Company’s 2011 Equity Incentive Plan

At June 30, 2017, there were 5,579,822 shares of common stock available for issuance under the Plan.

Shares Reserved for Issuance

At June 30, 2017, there were 10,629,565 shares of common stock reserved for issuance pursuant to unexercised warrants and stock options, or available for issuance under the Plan.

Dividends

The Company has not paid any dividends to date.

Earnings Per Share

6 Months Ended

Jun. 30, 2017

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the period, including stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Basic		18,449,210		18,671,648		18,561,453		18,565,198
Effect of exercise of warrants		363,834		-		-		-
Effect of exercise of stock options		-		-		-		-
Diluted		18,813,044		18,671,648		18,561,453		18,565,198

As a result of the net loss presented for the Current Year Six Months, Prior Year Quarter and Prior Year Six Months, the Company calculated diluted earnings per share using basic weighted-average shares outstanding for those periods, as utilizing diluted shares would be anti-dilutive to loss per share.

The computation of diluted EPS excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Stock options and warrants		4,684,250		4,966,043		5,049,743		4,966,043

Income Tax

6 Months Ended

Jun. 30, 2017

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

Income Tax

The effective income tax rate for the Current Quarter and the Prior Year Quarter was approximately 72% and 70%, respectively, resulting in an income tax provision (benefit) of $557,000 and $(208,000), respectively.

The effective income tax rate for the Current Six Months and the Prior Year Six Months was approximately 122% and 66%, respectively, resulting in an income tax provision (benefit) of $1,013,000 and $(259,000), respectively.

In the Current Quarter, the effective tax rate was primarily attributable to the tax impact from the vesting of restricted shares of common stock, which was treated as a discrete item for tax purposes. This item increased the effective rate by 7% for the Current Quarter and 57% for the Current Six Months, respectively. The effective tax rate was also attributable to recurring permanent differences. Based on the amount of income before income taxes compared to the recurring permanent differences, the effective rate increased approximately by 31% for both the Current Quarter and Current Six Months.

During the Prior Year Quarter and the Prior Year Six Months, the respective effective tax rates were attributable to recurring permanent differences. Based on the amount of loss from continuing operations before income taxes compared to the permanent differences, the effective rate increased by 29% and 25% for the Prior Year Quarter and the Prior Year Six Months, respectively.

Related Party Transactions

6 Months Ended

Jun. 30, 2017

Related Party Transactions

Benjamin Malka

Concurrent with the acquisition of the H Halston Brand on December 22, 2014, the Company entered into a license agreement with The H Company IP, LLC (“HIP”), which was subsequently amended September 1, 2015. Benjamin Malka, a director of the Company, is a 25% equity holder of HIP’s parent company, House of Halston LLC (“HOH”), and Chief Executive Officer of HOH. The HIP license agreement provides for royalty payments including guaranteed minimum royalties to be paid to the Company during the initial term that expires on December 31, 2019.

On September 1, 2015, the Company entered into a license agreement with Lord and Taylor, LLC (the “L&T License”) and simultaneously amended the H Halston License Agreement eliminating HIP’s minimum guaranteed royalty obligations, provided the L&T License is in effect. In addition, the Company entered into a sublicense agreement with HIP obligating the Company to pay HIP a fee on an annual basis the greater of (i) 50% of royalties received under the L&T License from H Halston products or (ii) guaranteed minimum royalties. Provided that Lord & Taylor, LLC is paying the Company at least $1,000,000 per quarter under the L&T License, the remaining contractually required guaranteed minimum royalties are equal to $0.75 million, $0.75 million, $1.5 million, and $1.75 million for the twelve months ending January 31, 2018, 2019, 2020, and 2021, respectively. Cumulative fees paid to HIP by the Company or on the Company’s behalf through June 30, 2017 were $0.19 million.

The Company recorded $0 and $28,000 of HIP fees (as a reduction to net revenue) for the Current Quarter and the Prior Year Quarter, respectively. The Company recorded approximately $9,000 and $62,000 of HIP fees (as a reduction to net revenue) for the Current Six Months and the Prior Year Six Months, respectively. In June 2017, the Company had a prepaid balance of $0.2 million to HIP to be applied against future fees due to HIP, which is recorded as a prepaid in current assets as of June 30, 2017.

HOH has also entered into an arrangement with another licensee of the Company to supply Halston-branded apparel for the subsequent sale of such product to end customers. Under the Company’s separate pre-existing licensing agreements in place with the aforementioned other licensee and with HIP as described above, the Company earns royalties on the sales of such Halston-branded products.

Edward Jones, III

During the Current Six Months and Prior Year Six Months, Edward Jones, III, a director of the Company, performed consulting services for and received compensation from a certain licensee of the Company. Under the terms of the Company’s agreement with this certain licensee, the licensee may supply the Company’s branded products to the Company’s other licensees. Under the terms of the Company’s separate pre-existing agreements with other licensees, the Company would earn royalties on the sales of such branded products sold to end customers.

On January 31, 2017, the Company entered into a two-year consulting agreement (the “QTR Consulting Agreement”) with Jones Texas, Inc. (“JTI”), whose controlling shareholder is Edward Jones, III, a director of the Company, pursuant to which JTI shall cause Mr. Jones to provide consulting services in connection with the Company’s short-lead production platform fashion program and other projects. Pursuant to the QTR Consulting Agreement, the Company issued an aggregate of 50,000 shares of common stock to JTI, of which 25,000 shares vested immediately, and 25,000 shares shall vest on January 31, 2018; however, up to 25,000 shares of common stock are subject to forfeiture if the Company’s business with suppliers of women’s apparel is materially diminished, as defined in the QTR Consulting Agreement. On June 18, 2017, based upon meeting certain performance targets relating to the Company’s short-lead production platform business as provided in the January 31, 2017 QTR Consulting Agreement, the Company issued an additional 28,334 shares of common stock to JTI, of which 14,167 shares vested immediately, resulting in the recognition of compensation expense of $79,000, and the remaining 14,167 shares shall vest on January 31, 2018. The Company also paid JTI a cash consulting fee of $75,000 on January 30, 2017 and an additional cash consulting fee of $75,000 on April 28, 2017 relating to other projects. As of June 30, 2017, there was no additional compensation owed to JTI.

Facility Exit Costs

6 Months Ended

Jun. 30, 2017

Restructuring and Related Activities [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

Facility Exit Costs

In June 2016, the Company relocated its corporate offices and operations from 475 Tenth Avenue in New York City to 1333 Broadway in New York City. In connection with the exit from its former office location, the Company recognized a liability at the exit and cease-use date for the remaining lease obligation associated with 475 Tenth Avenue, based on the remaining contractual lease payments less estimated sublease rentals, discounted to present value using a credit-adjusted risk-free rate. The Company recorded a net non-cash charge of approximately $648,000 associated with the recognition of this liability in the second quarter of 2016.

The remaining balance of the exit cost liability related to the former office space was approximately $713,000 as of June 30, 2017, of which $160,000 was recorded in other current liabilities and $553,000 was recorded in other long-term liabilities in the accompanying unaudited condensed consolidated balance sheets. The balance of this liability will be paid out over a period of approximately 5 years, through February 2022.

A summary of the activity related to the exit cost liability for the Current Six Months is as follows:

($ in thousands)
Balance as of January 1, 2017	$	783
Cash payments, net		(56)
Adjustment to liability (revision to estimated cash flows)		(25)
Accretion		11
Balance as of June 30, 2017	$	713

Trademarks, Goodwill and Other Intangibles (Tables)

6 Months Ended

Jun. 30, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill [Table Text Block]

Trademarks and other intangibles, net consist of the following:

		June 30, 2017
	Weighted-
	Average
	Amortization	Gross Carrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	96,694	$	-	$	96,694
Trademarks (definite-lived)	15 years		15,463		1,973		13,490
Licensing agreements	4 years		2,000		2,000		-
Non-compete agreement	7 years		562		201		361
Copyrights and other intellectual property	10 years		190		62		128
Total		$	114,909	$	4,236	$	110,673

		December 31, 2016
	Weighted-
	Average
	Amortization	Gross Carrying		Accumulated		Net Carrying
($ in thousands)	Period	Amount		Amortization		Amount
Trademarks (indefinite-lived)	n/a	$	96,676	$	-	$	96,676
Trademarks (definite-lived)	15 years		15,463		1,459		14,004
Licensing agreements	4 years		2,000		2,000		-
Non-compete agreement	7 years		562		160		402
Copyrights and other intellectual property	10 years		190		52		138
Total		$	114,891	$	3,671	$	111,220

Debt (Tables)

6 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Schedule of Debt [Table Text Block]

The Company’s net carrying amount of debt was comprised of the following:

	June 30,		December 31,
($ in thousands)	2017		2016
Xcel Term Loan	$	20,000	$	25,250
Unamortized deferred finance costs related to term loan		(429)		(509)
IM Seller Note		2,918		3,627
Ripka Seller Notes		523		504
Contingent obligation - JR Seller		200		200
Contingent obligation - CW Seller		2,850		2,850
Total		26,062		31,922
Current portion (i)		4,043		6,427
Long-term debt	$	22,019	$	25,495

(i)

Schedule of Maturities of Long-term Debt [Table Text Block]

the aggregate remaining scheduled annual principal payments under the Second Amendment to the Amended Loan Agreement were as follows:

($ in thousands)	Amount of
	Principal
Year Ending December 31,	Payment
2017 (July 1 through December 31)	$	500
2018		4,000
2019		4,000
2020		4,000
2021		7,500
Total	$	20,000

Debt Instrument Principal Payments [Table Text Block]

the aggregate remaining annual principal payments under the IM Seller Note were as follows:

($ in thousands)	Amount of
	Principal
Year Ending December 31,	Payment
2017 (July 1 through December 31)	$	717
2018		1,459
2019		742
Total	$	2,918

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2017

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]

The fair values of the options granted during the Current Six Months were estimated at the date of grant using the Black-Scholes option pricing model with the following assumptions:

Expected Volatility	33.69 – 35.20	%
Expected Dividend Yield	0	%
Expected Life (Term)	3.25 – 5.42 years
Risk-Free Interest Rate	1.52 – 2.02	%

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of the Company’s stock options activity for the Current Six Months is as follows:

					Weighted
					Average
			Weighted		Remaining
			Average		Contractual		Aggregate
	Number of		Exercise		Life		Intrinsic
	Options		Price		(in Years)		Value
Outstanding at January 1, 2017		2,436,000	$	5.98		4.38	$	-
Granted		815,000		4.62
Canceled		-		-
Exercised		-		-
Expired/Forfeited		(93,000)		5.02
Outstanding at June 30, 2017, and expected to vest		3,158,000	$	5.66		4.54	$	-
Exercisable at June 30, 2017		811,670	$	6.01		3.61	$	-

Schedule of Stock Options Roll Forward [Table Text Block]

The following table summarizes the Company’s stock option activity for non-vested options for the Current Six Months:

			Weighted
			Average
	Number of		Grant Date
	Options		Fair Value
Balance at January 1, 2017		2,294,667	$	1.39
Granted		815,000		1.07
Vested		(670,337)		1.49
Forfeited or Canceled		(93,000)		1.01
Balance at June 30, 2017		2,346,330	$	1.32

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]

A summary of the Company’s restricted stock activity for the Current Six Months is as follows:

			Weighted
	Number of		Average
	Restricted		Grant Date
	Shares		Fair Value
Outstanding at January 1, 2017		3,171,685	$	5.12
Granted		126,334		3.18
Canceled		-		-
Vested		(768,431)		4.20
Expired/Forfeited		(1,000)		9.00
Outstanding at June 30, 2017		2,528,588	$	5.29

Warrant [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of the Company’s warrants activity for the Current Six Months is as follows:

					Weighted
					Average
			Weighted		Remaining
			Average		Contractual		Aggregate
	Number of		Exercise		Life		Intrinsic
	Warrants		Price		(in Years)		Value
Outstanding and exercisable at January 1, 2017		1,966,743	$	6.76		2.81	$	-
Granted		-		-
Canceled		-		-
Exercised		-		-
Expired/Forfeited		(75,000)		(5.50)
Outstanding and exercisable at June 30, 2017		1,891,743	$	6.81		2.42	$	-

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2017

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Basic		18,449,210		18,671,648		18,561,453		18,565,198
Effect of exercise of warrants		363,834		-		-		-
Effect of exercise of stock options		-		-		-		-
Diluted		18,813,044		18,671,648		18,561,453		18,565,198

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

The computation of diluted EPS excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Stock options and warrants		4,684,250		4,966,043		5,049,743		4,966,043

Facility Exit Costs (Tables)

6 Months Ended

Jun. 30, 2017

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs [Table Text Block]

A summary of the activity related to the exit cost liability for the Current Six Months is as follows:

($ in thousands)
Balance as of January 1, 2017	$	783
Cash payments, net		(56)
Adjustment to liability (revision to estimated cash flows)		(25)
Accretion		11
Balance as of June 30, 2017	$	713

Nature of Operations, Background, and Basis of Presentation (Details Textual) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2016
Prior Period Reclassification Adjustment	$ 36,000	$ 106,000
Sales Revenue, Net [Member]
Prior Period Reclassification Adjustment	4,000	35,000
Selling, General and Administrative Expenses [Member]
Prior Period Reclassification Adjustment	$ 32,000	$ 71,000

Trademarks, Goodwill and Other Intangibles (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Finite and Indefinite-Lived Intangible Assets [Line Items]
Gross Carrying Amount, Total	$ 114,909	$ 114,891
Accumulated Amortization	4,236	3,671
Net Carrying Amount, Total	$ 110,673	$ 111,220
Non-compete agreement [Member]
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted-Average Amortization Period (Years)	7 years	7 years
Gross Carrying Amount (definite-lived)	$ 562	$ 562
Accumulated Amortization	201	160
Net Carrying Amount	$ 361	$ 402
Copyrights and other intellectual property [Member]
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted-Average Amortization Period (Years)	10 years	10 years
Gross Carrying Amount (definite-lived)	$ 190	$ 190
Accumulated Amortization	62	52
Net Carrying Amount	$ 128	$ 138
Trademarks [Member]
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted-Average Amortization Period (Years)	15 years	15 years
Gross Carrying Amount (indefinite-lived)	$ 96,694	$ 96,676
Gross Carrying Amount (definite-lived)	15,463	15,463
Accumulated Amortization	1,973	1,459
Net Carrying Amount	13,490	14,004
Net Carrying Amount, Total	$ 96,694	$ 96,676
Licensing agreements [Member]
Finite and Indefinite-Lived Intangible Assets [Line Items]
Weighted-Average Amortization Period (Years)	4 years	4 years
Gross Carrying Amount (definite-lived)	$ 2,000	$ 2,000
Accumulated Amortization	2,000	2,000
Net Carrying Amount	$ 0	$ 0

Trademarks, Goodwill and Other Intangibles (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Research and Development Assets Acquired Other than Through Business Combination [Line Items]
Amortization of Intangible Assets	$ 282,000	$ 282,000	$ 565,000	$ 564,000
Goodwill	$ 12,371,000		$ 12,371,000		$ 12,371,000

Significant Contracts (Details Textual) - Royalty Agreement With QVC [Member] - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Business Acquisition [Line Items]
QVC Net Revenue	$ 6,780	$ 7,720	$ 14,010	$ 14,950
QVC Net Revenue, Percentage	81.00%	85.00%	83.00%	86.00%
QVC Accounts Receivable, Gross	$ 6,830		$ 6,830		$ 5,890
Accounts Receivables, Percentage	78.00%		78.00%		85.00%

Debt (Details) - USD ($)
$ in Thousands

Jun. 30, 2017

Dec. 31, 2016

Debt Instrument [Line Items]

Unamortized deferred finance costs related to term loan

$ (429)

$ (509)

Total

26,062

31,922

Current portion

^[1]

4,043

6,427

Long-term debt

22,019

25,495

Xcel Term Loan [Member]

Debt Instrument [Line Items]

Term Loan

20,000

25,250

IM Seller Note [Member]

Debt Instrument [Line Items]

Seller Note

2,918

3,627

JR Seller [Member]

Debt Instrument [Line Items]

Contingent obligation

200

Ripka Seller Notes [Member]

Debt Instrument [Line Items]

Seller Note

523

504

CW Seller [Member]

Debt Instrument [Line Items]

Contingent obligation

$ 2,850

[1]	The current portion of long-term debt as of June 30, 2017 consists of (a) $2.5 million related to the Xcel Term Loan, (b) $1.443 million related to the IM Seller Note, and (c) $100 thousand related to the Ripka Earn-Out.

Debt (Details 1) - Xcel Term Loan [Member] - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
2017 (July 1 through December 31)	$ 500
2018	4,000
2019	4,000
2020	4,000
2021	7,500
Total	$ 20,000	$ 25,250

Debt (Details 2) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Total	$ 26,062	$ 31,922
I M Ready Made L L C [Member]
Debt Instrument [Line Items]
2017 (July 1 through December 31)	717
2018	1,459
2019	742
Total	$ 2,918

Debt (Details Textual)	1 Months Ended				3 Months Ended			6 Months Ended		12 Months Ended
Debt (Details Textual)	Dec. 21, 2016 USD ($)	Feb. 26, 2016 USD ($)	Dec. 24, 2013 $ / shares	Sep. 29, 2011 USD ($)	Jun. 30, 2017 USD ($) $ / shares	Dec. 31, 2016 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($) $ / shares	Jun. 30, 2016 USD ($)	Dec. 31, 2021 USD ($)	Mar. 31, 2019 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	May 15, 2018 USD ($)
Debt Instrument [Line Items]
Long-term Debt, Contingent Payment of Principal or Interest								the Company shall pay an early termination fee equal to the principal amount outstanding under the Term Loan on the date of prepayment, multiplied by: (i) two percent (2.00%) if the Xcel Term Loan is prepaid on or after the closing date and on or before the second anniversary of the closing date; or (ii) one percent (1.00%) if the Xcel Term Loan is prepaid after the second anniversary of the closing date and on or before the third anniversary of the closing date.
Interest Expense, Debt					$ 304,000		$ 352,000	$ 632,000	$ 663,000
Minimum Liquidity Covenants					3,000,000			3,000,000
Long-term Debt, Total					26,062,000	$ 31,922,000		26,062,000						$ 31,922,000
Long-term Debt, Current Maturities, Total					3,943,000	$ 6,427,000		3,943,000						6,427,000
Ripka Seller Notes [Member]
Debt Instrument [Line Items]
Interest Expense, Debt					9,000		9,000	19,000	17,000
Debt Conversion, Original Debt, Amount								600,000
Remaining Outstanding Value Of Long Term Debt Or Borrowing					$ 523,000			$ 523,000
Xcel Term Loan [Member]
Debt Instrument [Line Items]
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate					5.10%			5.10%
Interest Expense, Debt					$ 287,000		$ 348,000	$ 596,000	663,000
Maximum Capital Expenditures of Guarantor and its Subsidiaries														2,650,000
Minimum Fixed Charge Ratio, Start Range						1.00	1.20
Minimum Fixed Charge Ratio, End Range						1.00		1.00
Minimum Liquidity Covenants					5,000,000			$ 5,000,000
Minimum Net Worth Required for Compliance					90,000,000	$ 90,000,000		90,000,000						90,000,000
Long-term Debt, Current Maturities, Total					2,500,000			$ 2,500,000
Debt Instrument, Periodic Payment, Principal		$ 27,875,000
Xcel Term Loan [Member] \| Fiscal Year 2017 [Member]
Debt Instrument [Line Items]
Minimum Earning Before Interest Taxes Depreciation And Amortization								not less than $7,000,000
Xcel Term Loan [Member] \| Fiscal Year 2018 and 2019 [Member]
Debt Instrument [Line Items]
Minimum Earning Before Interest Taxes Depreciation And Amortization								not less than $8,000,000
Xcel Term Loan [Member] \| Fiscal Year 2020 and Thereafter [Member]
Debt Instrument [Line Items]
Minimum Earning Before Interest Taxes Depreciation And Amortization								not less than $9,000,000
Xcel Term Loan [Member] \| Scenario, Forecast [Member]
Debt Instrument [Line Items]
Maximum Capital Expenditures of Guarantor and its Subsidiaries													$ 700,000
Debt Instrument, Increase (Decrease) in Periodic Payment, Principal										$ (1,000,000)			1,000,000
Xcel Term Loan [Member] \| Scenario, Forecast [Member] \| Second Amendment [Member]
Debt Instrument [Line Items]
Debt Instrument, Increase (Decrease) in Periodic Payment, Principal										$ (750,000)			$ 750,000
C Wonder Earn-Out [Member]
Debt Instrument [Line Items]
Earn Out Payments					2,850,000			$ 2,850,000
Loans Payable [Member]
Debt Instrument [Line Items]
Long-term Debt, Current Maturities, Total						4,000,000								4,000,000
Ripka Earn-Out [Member]
Debt Instrument [Line Items]
Long-term Debt, Principal Payments					100,000			100,000
Royalty Earn Out Value								5,000,000
Earn Out Payments					3,050,000	$ 3,050,000		3,050,000						$ 3,050,000
Royalty Revenue, Total								1,000,000
Long-term Debt, Total					$ 3,780,000			$ 3,780,000
Floor Price Per Share for Conversion of Debt \| $ / shares					$ 7.00			$ 7.00
Decrease In Maximum Amount of Earn-Out Consideration	$ 375,000
Earn-Out Consideration Payable in Cash	$ 175,000
Ripka Earn-Out [Member] \| Scenario, Forecast [Member]
Debt Instrument [Line Items]
Long-term Debt, Principal Payments												$ 200,000
Earn-Out Consideration Payable in Cash															$ 100,000
Royalty Income, Nonoperating											$ 6,000,000	$ 6,000,000
IM Seller Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount				$ 7,377,000
Stated Interest Rate on Note Payable				0.25%
Subordinated Borrowing, Interest Rate				9.25%
Debt Instrument, Unamortized Discount				$ 1,740,000
Imputed Annual Interest Rate				9.00%
Initial Outstanding Value of Long-term Debt or Borrowing				$ 5,637,000
Initial Prepaid Interest				$ 123,000
Exercise Price of Common Stock \| $ / shares			$ 4.50
Interest Expense, Debt					$ 16,000		$ 69,000	$ 36,000	$ 140,000
Long-term Debt, Current Maturities, Total					$ 1,443,000			$ 1,443,000
Debt Instrument Amended Description								(1) revise the maturity date to March 31, 2019, (2) require six semi-annual principal and interest installment payments of $750,000, commencing on September 30, 2016 and ending on March 31, 2019, (3) revise the stated interest rate to 2.236% per annum, (4) allow for optional prepayments at any time at the Company’s discretion without premium or penalty, and (5) require that all payments of principal and interest be made in cash. Management assessed and determined that this amendment represented a debt modification and, accordingly, no gain or loss was recorded.
Debt Instrument, Maturity Date								Mar. 31, 2019

Stockholders' Equity (Details)	6 Months Ended
Stockholders' Equity (Details)	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected Volatility Rate, Minimum	33.69%
Expected Volatility Rate, Maximum	35.20%
Expected Dividend Yield	0.00%
Risk-Free Interest Rate, Minimum	1.52%
Risk-Free Interest Rate, Maximum	2.02%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected Life (Term)	3 years 3 months
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected Life (Term)	5 years 5 months 1 day

Stockholders' Equity (Details 1) - USD ($)	6 Months Ended	12 Months Ended
Stockholders' Equity (Details 1) - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options, Outstanding, Beginning Balance	2,436,000
Number of Options, Granted	815,000
Number of Options, Canceled	0
Number of Options, Exercised	0
Number of Options, Expired/Forfeited	(93,000)
Number of Options, Outstanding, Ending Balance	3,158,000	2,436,000
Number of Options, Exercisable at Beginning Balance	811,670
Weighted Average Exercise Price, Outstanding, Beginning Balance	$ 5.98
Weighted-Average Exercise Price, Granted	4.62
Weighted-Average Exercise Price Canceled	0
Weighted-Average Exercise Price, Exercised	0
Weighted-Average Exercise Price, Expired/Forfeited	5.02
Weighted Average Exercise Price, Outstanding, Ending Balance	5.66	$ 5.98
Weighted-Average Exercise Price, Exercisable at December 31, 2016	$ 6.01
Weighted Average Remaining Contractual Life (in years)	4 years 6 months 14 days	4 years 4 months 17 days
Exercisable Weighted Average Remaining Contractual Life (in years)	3 years 7 months 10 days
Aggregate Intrinsic Value, Outstanding	$ 0	$ 0
Aggregate Intrinsic Value, Exercisable	$ 0

Stockholders' Equity (Details 2)	6 Months Ended
Stockholders' Equity (Details 2)	Jun. 30, 2017 $ / shares shares
Number of Options
Granted	815,000
Employee Stock Option [Member]
Number of Options
Beginning Balance	2,294,667
Granted	815,000
Vested	(670,337)
Forfeited or Canceled	(93,000)
Ending Balance	2,346,330
Weighted Average Grant Date Fair Value
Beginning Balance \| $ / shares	$ 1.39
Granted \| $ / shares	1.07
Vested \| $ / shares	1.49
Forfeited or Canceled \| $ / shares	1.01
Ending Balance \| $ / shares	$ 1.32

Stockholders' Equity (Details 3) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended	12 Months Ended
	Jan. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Restricted stock Granted	50,000
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Outstanding, Beginning Balance	1,966,743	1,966,743
Number of Restricted stock Granted		0
Number of Warrants, Canceled		0
Number of Warrants, Exercised		0
Number of Warrants, Expired/Forfeited		(75,000)
Number of Warrants, Outstanding, Ending Balance		1,891,743	1,966,743
Weighted-Average Exercise Price, Outstanding, Beginning Balance	$ 6.76	$ 6.76
Weighted-Average Exercise Price, Granted		0
Weighted-Average Exercise Price, Canceled		0
Weighted-Average Exercise Price, Exercised		0
Weighted-Average Exercise Price, Expired/Forfeited		(5.50)
Weighted-Average Exercise Price, Outstanding, Ending Balance		$ 6.81	$ 6.76
Weighted Average Remaining Contractual Life (in Years)		2 years 5 months 1 day	2 years 9 months 22 days
Aggregate Intrinsic Value, Outstanding		$ 0	$ 0

Stockholders' Equity (Details 4) - Restricted Stock [Member] - $ / shares	1 Months Ended		6 Months Ended
	Jan. 31, 2018	Jan. 31, 2017	Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Restricted Shares, Outstanding, Beginning Balance		3,171,685	3,171,685
Number of Restricted Shares, Granted		50,000	126,334
Number of Restricted Shares, Canceled			0
Number of Restricted Shares, Vested	25,000		(768,431)
Number of Restricted Shares, Expired/Forfeited			(1,000)
Number of Restricted Shares, Outstanding, Ending Balance			2,528,588
Weighted-Average Exercise Price, Outstanding, Beginning Balance		$ 5.12	$ 5.12
Weighted-Average Grant Date Fair Value, Granted			3.18
Weighted-Average Grant Date Fair Value, Canceled			0
Weighted-Average Grant Date Fair Value, Vested			4.2
Weighted-Average Grant Date Fair Value, Expired/Forfeited			9
Weighted-Average Exercise Price, Outstanding, Ending Balance			$ 5.29

Stockholders' Equity (Details Textual) - USD ($)	1 Months Ended								3 Months Ended		6 Months Ended
Stockholders' Equity (Details Textual) - USD ($)	Mar. 31, 2019	Mar. 31, 2018	Jun. 18, 2017	May 31, 2017	Mar. 31, 2017	Mar. 31, 2017	Jan. 31, 2017	Jan. 24, 2017	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense											$ 79,000
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross											815,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price											$ 4.62
Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense									$ 272,000	$ 329,000	$ 574,000	$ 349,000
Non Management Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross					150,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price					$ 2.70
Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross				15,000				500,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$ 2.60				$ 5.00
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized									2,515,000		$ 2,515,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition											2 years 5 months 23 days
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-based Compensation Expense									451,000	$ 1,124,000	$ 1,232,000	$ 2,316,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized									$ 1,169,000		$ 1,169,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition											1 year 7 months 24 days
Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Granted							50,000				126,334
Restricted Stock [Member] \| Non Management Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures						48,000
Restricted Stock [Member] \| Non Management Directors [Member] \| Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage					50.00%
Restricted Stock [Member] \| Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures			28,334				50,000
2011 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant									5,579,822		5,579,822
Common Stock, Capital Shares Reserved for Future Issuance									10,629,565		10,629,565
Common Stock, Eligible for Issuance									13,000,000		13,000,000
Scenario, Forecast [Member] \| Restricted Stock [Member] \| Non Management Directors [Member] \| Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	50.00%	50.00%

Earnings Per Share (Details) - shares	3 Months Ended		6 Months Ended
Earnings Per Share (Details) - shares	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Earnings Per Share Basic And Diluted [Line Items]
Basic	18,449,210	18,671,648	18,561,453	18,565,198
Diluted	18,813,044	18,671,648	18,561,453	18,565,198
Employee Stock Option [Member]
Earnings Per Share Basic And Diluted [Line Items]
Effect of exercise of options and Warrants	0	0	0	0
Warrant [Member]
Earnings Per Share Basic And Diluted [Line Items]
Effect of exercise of options and Warrants	363,834	0	0	0

Earnings Per Share (Details 1) - shares	3 Months Ended		6 Months Ended
Earnings Per Share (Details 1) - shares	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Employee Stock Option [Member] \| Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options and warrants	4,684,250	4,966,043	5,049,743	4,966,043

Income Tax (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Income Tax (Details Textual) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Taxes [Line Items]
Effective Income Tax Rate, Continuing Operations	72.00%	70.00%	122.00%	66.00%
Income Tax Expense (Benefit)	$ 557	$ (208)	$ 1,013	$ (259)
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent	7.00%		57.00%
Effective Income Tax Rate Reconciliation Permanent Differences, Percent	31.00%	29.00%	31.00%	25.00%

Related Party Transactions (Details Textual) - USD ($)	1 Months Ended				3 Months Ended		6 Months Ended
Related Party Transactions (Details Textual) - USD ($)	Jan. 31, 2018	Jan. 31, 2017	Jan. 30, 2017	Dec. 22, 2014	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Apr. 28, 2017
Related Party Transaction [Line Items]
Royalty Expense					$ 0	$ 28,000	$ 9,000	$ 62,000
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Period		50,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		25,000
Allocated Share-based Compensation Expense, Total							$ 79,000
Scenario, Forecast [Member]
Related Party Transaction [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	14,167
Licensing Agreements [Member]
Related Party Transaction [Line Items]
Operating Leases, Future Minimum Payments Receivable, in March 31, 2017		$ 190,000
Operating Leases, Future Minimum Payments Receivable, in January 31, 2018		750,000
Operating Leases, Future Minimum Payments Receivable, in January 31, 2019		750,000
Operating Leases, Future Minimum Payments Receivable, in January 31, 2020		1,500,000
Operating Leases, Future Minimum Payments Receivable, in January 31, 2021		$ 1,750,000
License Expiration Date				Dec. 31, 2019
Percentage Of Royalties							50.00%
Jones Texas, Inc [Member]
Related Party Transaction [Line Items]
Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation							25,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period							14,167
Consulting Fees For Period			$ 75,000
Due to Other Related Parties									$ 75,000
Jones Texas, Inc [Member] \| Scenario, Forecast [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, Common Stock	28,334
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	25,000
Benjamin Malka [Member]
Related Party Transaction [Line Items]
Equity Method Investment, Ownership Percentage				25.00%
Prepaid Royalties					$ 200,000		$ 200,000
Lord & Taylor [Member]
Related Party Transaction [Line Items]
Minimum Royalties Required Per Quarter							$ 1,000,000

Facility Exit Costs (Details) - USD ($) $ in Thousands	6 Months Ended
Facility Exit Costs (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
Restructuring Cost and Reserve [Line Items]
Accretion	$ 0	$ 648
Facility Exit Costs [Member]
Restructuring Cost and Reserve [Line Items]
Balance as of January 1, 2017	783
Cash payments, net	(56)
Adjustment to liability (revision to estimated cash flows)	(25)
Accretion	11
Balance as of June 30, 2017	$ 713

Facility Exit Costs (Details Textual) - Facility Exit Costs [Member] - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2017	Dec. 31, 2016
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 648,000
Restructuring Reserve		$ 713,000	$ 783,000
Restructuring Reserve, Current		160,000
Restructuring Reserve, Noncurrent		$ 553,000
Facility Exit Costs Payable period		approximately 5 years, through February 2022